SG-7(Xianggen Biology)

N/A

Report date: 2024/05/21 15:50:25
NMEFirst In Class

Base Information

Drug NameSG-7(Xianggen Biology)
Drug Alias NameSG-7(Xianggen Biology)SG7(Xianggen Biology)
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProteolysis
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Xianggen Biology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Xianggen Biology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A